Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05767554 · ClinicalTrials.gov registry record · NA

Depression, Experiential Diversity, and Behavioral Novelty

A NA study, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
77
Enrollment target

NCT05767554: Completed NA study, sponsored by University of Texas at Austin.

NCT05767554 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05767554, a NA study, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
77 participants
Enrollment target

Study Summary

The purpose of the study is to test whether changes in behavioral patterns are related to changes in depression. Depression is a psychological condition that involves persistent sad mood and/or an inability to enjoy pleasurable activities. Very stable behavioral patterns may be related to symptoms of depression. The aim of this study is to learn more about the relationship between symptoms of depression and behavioral patterns that are collected via global positioning system location data from a smart phone.

Primary Outcome

Level of depression symptoms assessed weekly by the Patient Health Questionnaire - 8 via smart phone survey. The PHQ-8 ranges from 0-24 with higher scores indicating more severe symptoms of depression.

Interventions

  • BEHAVIORAL Brief modified behavioral activation

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2023-04-21
Est. Completion 2024-03-31
Phase NA
University of Texas at Austin

257 total trials

What the finished NCT05767554 record still lists

NCT05767554 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Brief modified behavioral activation is the first listed.

NCT05767554 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05767554 about?

NCT05767554 is a clinical study titled "Depression, Experiential Diversity, and Behavioral Novelty". The purpose of the study is to test whether changes in behavioral patterns are related to changes in depression. Depression is a psychological condition that involves persistent sad mood and/or an inability to enjoy pleasurable activities. Very stable behavioral patterns may be related to symptoms o...

What is the current status of trial NCT05767554?

This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2023-04-21. Estimated completion is 2024-03-31.

What interventions are being tested in trial NCT05767554?

The interventions under investigation include: Brief modified behavioral activation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05767554?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05767554's enrollment target sits among peer trials

77 1062nd of 2000 higher than 939 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05767554, the US trial registry maintained by the National Library of Medicine. NCT05767554 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.